E.‐M. Rutanen

No ORCID on file · 2 papers in corpus · active 1997-2007

Study types

  • article 2
article 2007
Intrauterine release of progesterone antagonist ZK230211 is feasible and results in novel endometrial effects: a pilot study
·doi:10.1093/humrep/dem235

BACKGROUND: Continuous administration of progesterone antagonists (PAs) results in endometrial suppression and amenorrhoea in several model systems. We compared the effects of intrauterine release of a highly specific PA, ZK230211, to those…

article 1997
mRNA expression of insulin-like growth factor-I (IGF-I) is suppressed and those of IGF-II and IGF-binding protein-1 are constantly expressed in the endometrium during use of an intrauterine levonorgestrel system
·doi:10.1093/molehr/3.9.749

Insulin-like growth factors (IGF-I and IGF-II) are believed to mediate and modulate steroid hormone actions in the endometrium. In this study we determined the effects of an intrauterine system (IUS), releasing 20 microg levonorgestrel (LNG…